Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of June 15th – 21st, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
The newly public ‘Super State Operator’ Red White & Bloom (CSE: RWB) (OTCQX: TDRYD) has been quietly cornering the highly lucrative Michigan cannabis market and thanks to its first-mover advantage, RWB now controls a 22% market share in the Great Lakes State.
MindMed (NEO: MMED) (OTCQB: MMEDF) (FRA: BGHM) plans to use the Phase 1 Study to experiment with dosing methods to better understand how humans react to Ayahuasca’s active Psychedelic ingredient, DMT.
The deal between Charlotte’s Web (TSX: CWEB) (OTCQX: CWBHF) and Abacus Health Products (CSE: ABCS) (OTCQX: ABAHF), valued at CA$99 million ($68.2 million), would form one of the biggest vertically integrated hemp-derived CBD companies and give Charlotte’s Web about 35% of U.S. CBD sales.
Marijuana multistate operator Acreage Holdings (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0VZ) has secured a $15 million short-term loan with a whopping 60% yearly interest rate, the company said Wednesday.
In fact, according to analysts at Eight Capital, “The addressable market is incredibly large, and we’re still in the early innings of what any sort of psychedelic treatment could do to resolve some of these important issues.”
When you think of Cannabis Stocks, the idea of receiving dividends probably doesn’t come to mind. However, there are a handful of companies with close ties to the cannabis industry that do offer dividends. Here are three Marijuana Stocks with the highest dividend yields of all.
Last week, Numinus Wellness (TSXV: NUMI) (OTC: LKYSD) (FRA: LR23), a company that provides testing for Psychedelic therapies that address mental illness and addiction, announced that Health Canada approved to amend the company’s license to allow Numinus to conduct research to standardize the extraction of Psilocybin from mushrooms.
In addition, Brochstein also explores how COVID-19 could inspire Cannabis companies to work together to find more profit through unification on the legal market versus the illegal market. In a time where health and wellness supersede everything, quality assurance and safety measures are presenting a big opportunity for the legal market to thrive.
Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FRA: 496) continues to highlight the scientific merit of its ketamine treatments for Major Depressive Disorder (MDD) while demonstrating rapid onset efficacy and safety of its treatment processes. The company announced that its CEO, Dr. Roger McIntyre, and the Canadian Rapid Treatment Centre of Excellence (CRTCE) has been recently published in two peer-reviewed study journals focusing on ketamine’s safety, tolerability and effectiveness.
Brad Rogers, CEO of ‘Super State Operator’ Red White & Bloom (CSE: RWB) (OTC: TDRYD) shares his thoughts on the U.S. cannabis industry as well as his vision for RWB following the company’s successful IPO.